We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
REVIEW
[Uterine leiomyomas--risk factors].
Ginekologia Polska 2003 December
Uterine leiomyomas are benign tumours that arise from the smooth-muscle cells of the human uterus. They are clinically apparent in up to 20% of women and cause significant morbidity, including prolonged and heavy menstrual bleeding, pelvic pressure or pain and reproductive dysfunction. Surgery has been the mainstay of fibroid treatment and various minimally invasive procedures have been developed in addition to hysterectomy and abdominal myomectomy, but formation of new leiomyomas after these conservatives therapies remains a substantial problem. The pathophysiology of myomas is not well understood. We present some views of epidemiological, reproductive and environmental factors, which may stimulate myomas formation. We also present a brief survey of the literature about genetic predisposition, mutations, steroid hormone and growth factors concentration, which seems to pay an important role in fibrotic processes and angiogenesis observed during formation and growth of these tumours. New research into the basic biology of these neoplasms may add new treatment options for the future as the role of growth factors and genetic mutations in these tumours are better understood.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app